Experimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|6|728-737

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.6, 2016-02, pp. : 728-737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy Strategies for Spinal Cord Injury

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 6, 2015-06 ,pp. : 492-505

Bentham Science Publishers

Access to resources Recommend Favorite

From Discovery to Clinical Trials: Treatment Strategies for Central Neuropathic Pain after Spinal Cord Injury

By  

Current Pharmaceutical Design, Vol. 11, Iss. 11, 2005-04 ,pp. : 1411-4120

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury

By Esposito Emanuela   Cuzzocrea Salvatore  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 8, 2011-08 ,pp. : 943-959

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2830-2838

Bentham Science Publishers

Access to resources Recommend Favorite

Biomaterial Strategies for Delivering Stem Cells as a Treatment for Spinal Cord Injury

By  

Cells Tissues Organs, Vol. 202, Iss. 1-2, 2016-10 ,pp. : 42-51

Karger

Access to resources Recommend Favorite